Antifracture drugs consumption in Tuscany Region before the Target Project: A valuable model for the analysis of administrative database

Clinical Cases in Mineral and Bone Metabolism

Volumn 9, Issue 2, 2012, Pages 76-79

  Piscitelli, Prisco ^a   Parri, Simone ^a   Brandi, Maria Luisa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antifracture drugs; Osteoporosis; Private expenditures; Public expenditures

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; COLECALCIFEROL; IBANDRONIC ACID; NERIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; STRONTIUM RANELATE; ZOLEDRONIC ACID;

DRUG DELIVERY SYSTEM; DRUG USE; FEMUR FRACTURE; HEALTH CARE COST; HEALTH CARE SYSTEM; HIP FRACTURE; HUMAN; PRESCRIPTION; SHORT SURVEY;

EID: 84867394733     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Italian Statistics 2001-2008. National Institute for Statistics, Rome.
2. WHO statistical information system (WHOSIS), available at http://apps.who.int/whosis/database/life-tables/life-tables-process.cfm?path= whosis,life-tables&language=english.
3. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19(4):399-428.
4. Adami S, Giannini S, Giorgino R, Isaia G, Maggi S, Sinigaglia L, Filipponi P, Crepaldi G, Di Munno O. The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int 2003;14:198-207. (Pubitemid 40826232)
5. Siris ES, Brenneman SK, Barrett-Connor E, Miller PD, Sajjan S, Berger ML, Chen YT. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 2006;17(4):565-74.
6. Krieg MA, Cornuz J, Ruffieux C, Van Melle G, Büche D, Dambacher MA, Hans D, Hartl F, Häuselmann HJ, Kraenzlin M, Lippuner K, Neff M, Pancaldi P, Rizzoli R, Tanzi F, Theiler R, Tyndall A, Wimpfheimer C, Burckhardt P. Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study. J Bone Miner Res 2006 Sep;21(9):1457-63. (Pubitemid 44300052)
7. Maggi S, Noale M, Giannini S, Adami S, Defeo D, Isaia G, Sinigaglia L, Filipponi P, Crepaldi G. Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporosis Int 2006;17:237-244. (Pubitemid 43053587)
8. Piscitelli P, Iolascon G, Gimigliano F, Muratore M, Camboa P, Borgia O, Forcina B, Fitto F, Robaud V, Termini G, Rini GB, Gianicolo E, Faino A, Rossini M, Adami S, Angeli A, Distante A, Gatto S, Gimigliano R, Guida G. Incidence and costs of hip fractures vs. acute myocardial infarction in the Italian population: a 4 years survey. Osteoporos Int 2007;18:211-219. (Pubitemid 46090225)
9. Piscitelli P, Brandi ML, Chitano G, Argentiero A, Neglia C, Distante A, Saturnino L, Tarantino U. Epidemiology of Fragility Fractures in Italy. Clinical Cases in Mineral Bone Metabolism 2011;8(2):29-34.
10. Piscitelli P, Gimigliano F, Gatto S, Marinelli A, Gimigliano A, Marinelli P, Chitano G, Greco M, Di Paola L, Sbenaglia E, Benvenuto M, Muratore M, Quarta E, Calcagnile F, Colì G, Borgia O, Forcina B, Fitto F, Giordano A, Distante A, Rossini M, Angeli A, Migliore A, Guglielmi G, Guida G, Brandi ML, Gimigliano R, Iolascon G. Hip Fractures in Italy: 2000-2005 extension study, Osteoporosis International 2010;Vol.21(no.8): 1323-1330.
11. Piscitelli P, Chitano G, Greco M, Benvenuto M, Sbenaglia E, Colì G, Migliore A, Granata M, Iolascon G, Gimigliano R, Baggiani A, Distante A, Tarantino U, Rizzuti C, Brandi ML. Pharmaco-economic issues in the treatment of severe osteoporosis. Clinical Cases in Mineral and Bone Metabolism 2010;7(1):61-64.
12. Piscitelli P, Brandi ML, Tarantino U, Baggiani A, Distante A, Muratore M, Grattagliano V, Migliore A, Granata M, Guglielmi G, Gimigliano R, Iolascon G. Incidence and socioeconomic burden of hip fractures in Italy: extension study 2003-2005. Reumatismo 2010 Apr-Jun;62(2):113-8.
13. Tarantino U, Capone A, Planta M, D'Arienzo M, Letizia Mauro G, Impagliazzo A, Formica A, Pallotta F, Patella V, Spinarelli A, Pazzaglia U, Zarattini G, Roselli M, Montanari G, Sessa G, Privitera M, Verdoia C, Corradini C, Feola M, Padolino A, Saturnino L, Scialdoni A, Rao C, Iolascon G, Brandi ML, Piscitelli P. The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther 2010;12(6):R226. Epub 2010 Dec 29.
14. Piscitelli P, Metozzi A, Brandi ML, Nuti R, Rizzuti C, Orlandini E, Giorni L, Merlotti D. Pharmacological treatment of hip fractured patients in Italy: a simulation based on Tuscany regional database for the Target project. Clinical Cases in Mineral Bone Metabolism 2010;7(2):140-143.
15. Piscitelli P, Brandi ML, Nuti R, Rizzuti C, Giorni L, Giovannini V, Metozzi A, Merlotti D. The Target project in Tuscany: the first disease management model of regional project for the prevention of hip refractures in the elderly. Clinical Cases in Mineral Bone Metabolism 2010;7(3):251-254.
16. Piscitelli P, Tarantino U, Chitano G, Argentiero A, Neglia C, Agnello N, Saturnino L, Feola M, Celi M, Raho C, Distante A, Brandi ML. Updated incidence rates of fragility fractures in Italy. Clinical Cases in Mineral Bone Metabolism 2011;8(3):54-61.
17. OSMED Report 2010, available at http://www.iss.it/binary/pres/cont/OSMED- 2010.pdf.